Table 2 List of glycoproteins identified and their iTRAQ quantitative ratios obtained from the triplicate analysis of nonglycosylated peptides of normal and ovarian cancer sera

P01011

Alpha-1-antichymotrypsin

6

13.2

1.5±0.03

P01008

Antithrombin-III

7

14.4

1.5±0.07

P02763

Alpha-1-acid glycoprotein 1

4

17.4

1.3±0.14

P04114

Apolipoprotein B-100

63

12.8

1.3±0.09

P00748

Coagulation factor XII

3

4.1

1.3±0.39

P19652

Alpha-1-acid glycoprotein 2

3

12.9

1.3±0.17

P01009

Alpha-1-antitrypsin

12

26.3

1.2±0.23

P00738

Haptoglobin

12

26.4

1.2±0.02

P00450

Ceruloplasmin

11

10.6

1.2±0.02

P25311

Zinc-alpha-2-glycoprotein

5

17.1

1.1±0.02

P05155

Plasma protease C1 inhibitor

3

5.6

1.1±0.03

P36980

Complement factor H-related protein 2

3

11.1

1±0.20

P02790

Hemopexin

7

15.2

1±0.04

P0C0L4

Complement C4-A

26

14.3

1±0.05

P00734

Prothrombin

8

14.8

1±0.04

P08185

Corticosteroid-binding globulin

2

4.0

1±0.10

P02749

Beta-2-glycoprotein 1

2

7.5

0.9±0.08

P27169

Serum paraoxonase/arylesterase 1

5

13.0

0.9±0.05

O75882

Attractin

6

4.3

0.9±0.07

P08603

Complement factor H

17

15.0

0.9±0.11

P10909

Clusterin

6

11.6

0.9±0.03

P19823

Inter-alpha-trypsin inhibitor heavy chain H2

10

9.5

0.8±0.09

P03952

Plasma kallikrein

8

11.9

0.8±0.13

P04004

Vitronectin

4

7.3

0.8±0.03

P05546

Heparin cofactor 2

7

13.2

0.8±0.04

P01042

Kininogen-1

11

16.0

0.8±0.06

P02765

Alpha-2-HS-glycoprotein

7

19.4

0.8±0.03

P02787

Serotransferrin

26

41.4

0.7±0.06